Congo, Democratic Republic of the vs Uzbekistan: Previously treated cases tested for RR-/MDR-TB
Congo, Democratic Republic of the
85.0%
in 2024
Uzbekistan
86.0%
in 2024
Congo, Democratic Republic of the rank
100th
Uzbekistan rank
97th
Previously treated cases tested for RR-/MDR-TB over time
- Congo, Democratic Republic of the
- Uzbekistan
How they compare
Uzbekistan currently reports 86.0% against 85.0% in Congo, Democratic Republic of the, a difference of 1.0%.
Across all 19 years both countries report, Uzbekistan has been ahead every year.
Congo, Democratic Republic of the ranks 100th and Uzbekistan ranks 97th of 180 countries.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 13.3% | 11.6% | Uzbekistan |
| 2010s | 38.4% | 59.4% | 21.0% | Uzbekistan |
| 2020s | 83.8% | 97.2% | 13.4% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo, Democratic Republic of the or Uzbekistan?
- Uzbekistan, at 86.0% against 85.0% in Congo, Democratic Republic of the as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo, Democratic Republic of the and Uzbekistan?
- 1.0%, with Uzbekistan ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Uzbekistan?
- 19 years are reported by both, from 2006 to 2024.
- How do Congo, Democratic Republic of the and Uzbekistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo, Democratic Republic of the ranks 100th and Uzbekistan ranks 97th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.